• Amanda Freitas Mendonça Firmino Unievangélica
  • Vitor Gabriel Botelho Davi Universidade Evangélica de Anápolis – UniEVANGÉLICA
  • Nicole Gundim de Souza Universidade Evangélica de Anápolis – UniEVANGÉLICA
  • Pedro Augusto Tavares de Sá Universidade Evangélica de Anápolis – UniEVANGÉLICA
  • Caio de Moura Torres Universidade Evangélica de Anápolis – UniEVANGÉLICA
  • Humberto de Sousa Fontura Universidade Evangélica de Anápolis – UniEVANGÉLICA




A very common disease that affects thousands of people around the world and, when not treated correctly, can worsen and lead to death is venous thromboembolism (VTE). Patients affected by VTE may be linked to other concomitant pathologies, including neoplasia. Therefore, based on a mini literature review, a correlation was observed between patients with or that already had cancer and venous thromboembolism (VTE). The reviewed articles that supported this summary are intended to support or rule out the existence of correlation or risk factors and treatments based on this relationship. In this sense, there was consensus on the existence of a link between cancer and a greater propensity for VTE and several factors that lead to this involvement, such as the type of neoplasm, age group, sex, in addition to various symptomatic manifestations. In addition, the correlation between neoplasia and venous thromboembolism helps to elucidate key points on improving both the treatment and prophylaxis of VTE.


Carrier, Marc et al. “Treatment Algorithm in Cancer-Associated Thrombosis: Updated Canadian Expert Consensus.” Current oncology (Toronto, Ont.). V. 28, p. 5434-5451, 2021

Connell, C. et al. Treatment of Cancer-Associated Venous Thromboembolism with Low-Molecular-Weight Heparin or Direct Oral Anticoagulants: Patient Selection, Controversies, and Caveats. The Oncologist. V. 26, p. 8-16, 2020

Gimbel IA, et al. Pulmonary embolism at autopsy in cancer patients. J Thromb Haemost.; V. 19, p. 1228–1235, 2021

Giustozzi, M. et. al. Clinical characteristics and outcomes of incidental venous thromboembolism in cancer patients: Insights from the Caravaggio study. J Thromb Haemost; V. 19, p. 2751–2759, 2021

Hisada Y, Mackman N. Cancer-associated pathways and biomarkers of venous thrombosis. Blood; V. 130, p. 1499-1506, 2017

Lijfering, Willem M et al. “Predicting the risk of recurrent venous thrombosis: What the future might bring.” Journal of thrombosis and haemostasis: JTH; V. 17,9, p. 1522-1526, 2019

Mahajan A. et al. The Epidemiology of Cancer-Associated Venous Thromboembolism: An Update. Semin Thromb Hemost.; V. 45, p.321-325, 2019

Semestre, M. Soudet, S. Epidemiology and risk factors for cancer-associated

thrombosis. Journal de Médecine Vasculaire. V. 45, p. 653-657, 2020

Silvis SM. et al. Câncer e risco de trombose venosa cerebral: um estudo caso-controle. J Thromb Haemost; V. 16, p. 90–95, 2018